A national plan for screening cognitive disorders, namely dementia and Alzheimer's, in the elderly aged 60 to 75 years is underway. About five percent of people over 65 years old have moderate and severe dementia, Afrouz Saffarifar, an official with the Welfare Organization, said on Saturday. The elderly population in Iran has doubled from five ...

MNA Researchers at Iranian Institute of Medicinal Plants will unveil on Tue. a type of herbal medicine Melitropic that can be used in treatment of Alzheimers disease. The researchers used ancient and indigenous knowledge of the Iranian land in treatment of brain problems and conducted extensive research on the latest studies in the world on this ...

Tehran, March 2,The Iran Project Iranian scientist who has recently won the U.S Alzheimer's Institute's research grants says Iran will become a hub for Alzheimer treatment in the world by next 6 years. Speaking in an interview with Mehr News Agency, Kourosh Shahpasand, who has won the research grant of the U.S Alzheimer's Institute and has lately ...

TEHRAN, Sep. 06 (MNA) Biotechnology Research Center (Zist Fanavari) has launched development of 3 recombinant medicines including for MS and Alzheimers disease. Azin Mehrdad, the head of Biotechnology Research Center in Iranian Research OrganizationforScienceand Technology told Mehr News that the Center was working on development of three medicines ...